Fogg MH - Search Results

1

The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.

Fogg MH, Kaur A, Cho YG, Wang F. Fogg MH, et al. J Virol. 2005 Oct;79(20):12681-91. doi: 10.1128/JVI.79.20.12681-12691.2005. J Virol. 2005. PMID: 16188971 Free PMC article.

2

CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.

Leskowitz RM, Zhou XY, Villinger F, Fogg MH, Kaur A, Lieberman PM, Wang F, Ertl HC. Leskowitz RM, et al. Among authors: fogg mh. J Virol. 2013 Aug;87(15):8351-62. doi: 10.1128/JVI.00852-13. Epub 2013 May 22. J Virol. 2013. PMID: 23698300 Free PMC article.

3

Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.

Leskowitz R, Fogg MH, Zhou XY, Kaur A, Silveira EL, Villinger F, Lieberman PM, Wang F, Ertl HC. Leskowitz R, et al. Among authors: fogg mh. J Virol. 2014 May;88(9):4721-35. doi: 10.1128/JVI.03744-13. Epub 2014 Feb 12. J Virol. 2014. PMID: 24522914 Free PMC article.

4

Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma.

Fogg M, Murphy JR, Lorch J, Posner M, Wang F. Fogg M, et al. Virology. 2013 Jul 5;441(2):107-13. doi: 10.1016/j.virol.2013.03.016. Epub 2013 Apr 17. Virology. 2013. PMID: 23601786 Free PMC article.

5

Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a new world primate.

Fogg MH, Carville A, Cameron J, Quink C, Wang F. Fogg MH, et al. J Virol. 2005 Aug;79(15):10069-72. doi: 10.1128/JVI.79.15.10069-10072.2005. J Virol. 2005. PMID: 16014968 Free PMC article.

6

The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques.

Fogg MH, Garry D, Awad A, Wang F, Kaur A. Fogg MH, et al. J Immunol. 2006 Mar 15;176(6):3391-401. doi: 10.4049/jimmunol.176.6.3391. J Immunol. 2006. PMID: 16517707

7

Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.

Fogg MH, Wirth LJ, Posner M, Wang F. Fogg MH, et al. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3318-23. doi: 10.1073/pnas.0813320106. Epub 2009 Feb 11. Proc Natl Acad Sci U S A. 2009. PMID: 19211798 Free PMC article.

8

Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.

Orlova N, Fogg MH, Carville A, Wang F. Orlova N, et al. Among authors: fogg mh. Clin Vaccine Immunol. 2011 Sep;18(9):1427-34. doi: 10.1128/CVI.05126-11. Epub 2011 Jul 6. Clin Vaccine Immunol. 2011. PMID: 21734064 Free PMC article.

9

Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.

Orlova N, Wang F, Fogg MH. Orlova N, et al. Among authors: fogg mh. J Virol. 2011 Dec;85(23):12821-4. doi: 10.1128/JVI.05742-11. Epub 2011 Sep 14. J Virol. 2011. PMID: 21917961 Free PMC article.

10

An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.

Ohashi M, Fogg MH, Orlova N, Quink C, Wang F. Ohashi M, et al. Among authors: fogg mh. PLoS Pathog. 2012 Dec;8(12):e1003095. doi: 10.1371/journal.ppat.1003095. Epub 2012 Dec 27. PLoS Pathog. 2012. PMID: 23300447 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters